Showing results (191-200 of 1,748) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2017
Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the BladderElaine Chang, Anita L Sabichi, Yvonne H SadaJournal of Immunotherapy (Hagerstown, Md. : 1997)|March 29, 2019
Suppressive Characteristics of Umbilical Cord Blood-derived Regulatory T Cells After Ex Vivo Expansion on Autologous and Allogeneic T Effectors and Various Lymphoblastic CellsThitinee Vanichapol, Nutkridta Pongsakul, Supanart Srisala, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A hexon and fiber-modified adenovirus expressing CD40L improves the antigen presentation capacity of dendritic cellsLina Liljenfeldt, Di Yu, Liye Chen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
Ovarian tumor ascites CD14+ cells suppress dendritic cell-activated CD4+ T-cell responses through IL-10 secretion and indoleamine 2,3-dioxygenaseHannah E Goyne, Pamela J B Stone, Alexander F Burnett, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety studyGéraldine Gallot, Solène Vollant, Soraya Saïagh, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2014
Expression of MAGE-A3/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survivalMaha Ayyoub, Clara-Maria Scarlata, Ahmed Hamaï, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2014
Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanomaDi Chen, James Koropatnick, Nan Jiang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockadeWillemijn B Breunis, Eduardo Tarazona-Santos, Renee Chen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinomaP Mulders, C L Tso, S Pang, et al.Pageof 175